Olive M.. mGlu5 receptors: Neuroanatomy, pharmacology, and role in drug addiction. Current Psychiatry Reviews 2005; 1 (2):197-214.
Olive M. F.. mGlu5 receptors: neuroanatomy, pharmacology and role in drug addiction. Current Psychiatry Reviews 2005; 1 ():197-214.
Olive M. F., McGeehan A. J., Kinder J. R., McMahon T., Hodge C. W., Janak P. H., Messing R. O.. The mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine decreases ethanol consumption via a protein kinase C(epsilon)-dependent mechanism. Molecular Pharmacology 2005; 67 ():349-355.
Olive M., Triggle D. J.. Sleep Aids (Drugs: the Straight Facts). : Chelsea House Publications; 2005.
Onitilo A. A., Kio E. A., Singh A. K., Lazarchick J.. Cytogenetic remission with imatinib therapy in hypereosinophilic syndrome with trisomy 8 and resolution of severe cardiac dysfunction. Leukemia AND Lymphoma 2005; 46 (11):1667-1670.
Orwig K. S., Dix T. A.. Synthesis of C-alpha methylated carboxylic acids: isosteres of arginine and lysine for use as N-terminal capping residues in polypeptides. Tetrahedron Letters 2005; 46 (41):7007-7009.
Osawa Y., Hannun Y. A., Proia R. L., Brenner D. A.. Roles of AKT and sphingosine kinase in the antiapoptotic effects of bile duct ligation in mouse liver. Hepatology 2005; 42 (6):1320-1328.
Osawa Y., Uchinami H., Bielawski J., Schwabe R. F., Hannun Y. A., Brenner D. A.. Roles for C-16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha. Journal of Biological Chemistry 2005; 280 (30):27879-27887.
Osguthorpe J. D.. A century of otolarngyology-head and neck surgery as revealed in The Journal of the South Carolina Medical Association. Journal - South Carolina Medical Association 2005; 101 (7):241-7.
Osguthorpe J. D., Skoner J. M.. Surgical approaches to the oral cavity. Oral Cavity Reconstruction 2005; ():95-118.
Otake Y., Sengupta T. K., Bandyopadhyay S., Spicer E. K., Fernandes D. J.. Retinoid-induced apoptosis in HL-60 cells is associated with nucleolin down-regulation and destabilization of bcl-2 mRNA. Molecular Pharmacology 2005; 67 (1):319-326.
Otake Y., Sengupta T. K., Bandyopadhyay S., Spicer E. K., Fernandes D. J.. Retinoid-induced apoptosis in HL-60 cells is associated with nucleolin down-regulation and destabilization of Bcl-2 mRNA. Molecular Pharmacology 2005; 67 (1):319-26.
Padmanabhan V., Farghaly H., DuBose L. Q., Christiansen L., Hoda R. S.. HPV test should be requested in high-risk patients as an "anticipatory" positive test. Modern Pathology 2005; 18 ():73A.
Paintlia A. S., Paintlia M. K., Khan M., Vollmer T., Singh A. K., Singh I.. HMG-CoA reductase inhibitor augments survival and differentiation of oligodendrocyte progenitors in animal model of multiple sclerosis. FASEB Journal 2005; 19 (11):1407-1421.
Paintlia A. S., Paintlia M. K., Khan M., Vollmer T., Singh A. K., Singh I.. HMG-CoA reductase inhibitor augments survival and differentiation of oligodendrocyte progenitors in animal model of multiple sclerosis. FASEB JOURNAL 2005; 19 (11):1407-21.
Palesch Y. Y., Tilley B. C., Sackett D. L., Johnston K. C., Woolson R.. Applying a phase II futility study design to therapeutic stroke trials. Stroke 2005; 36 (11):2410-2414.
Palesch Y. Y., Tilley B. C., Sackett D. L., Johnston K. C., Woolson R.. Applying a phase II futility study design to therapeutic stroke trials.[see comment]. Stroke 2005; 36 (11):2410-4.
Palesch Y. Y., Tilley B. C., Sackett D. L., Johnston K. C., Woolson R.. Applying a phase II futility study design to therapeutic stroke trials. Stroke 2005; 36 (11):2410-4.
Pandey J. P.. More to Ab specificity than variable region. Scientist 2005; 19 (6):10-10.
Pandey J. P., Koga M., Yuki N.. Immunoglobulin KM allotypes are associated with the prevalence of autoantibodies to GD1a ganglioside, but not with susceptibility to the disease, in Japanese patients with Guillain-Barre syndrome. Neurogenetics 2005; 6 (4):225-228.
Pandey J. P., Koga M., Yuki N.. Immunoglobulin KM allotypes are associated with the prevalence of autoantibodies to GD1a ganglioside, but not with susceptibility to the disease, in Japanese patients with Guillain-Barre syndrome. Neurogenetics 2005; 6 (4):225-8.
Pandey J. P., Rocca K. M., ElGhazali G.. Significant differences in immunoglobulin GM allotype frequencies between two African sympatric ethnic groups with markedly differential susceptibility to malaria. FASEB JOURNAL 2005; 19 (4):A936-A936.
Pandey S. C., Chandler L., Nixon K., Crews F. T., Hensler J. G., Ukai W., Saito T.. Neurotrophic factor signaling in alcoholism. Alcoholism - Clinical and Experimental Research 2005; 29 (6):1098-1105.
Pannu J., Nakerakanti S., Gardner H., Shearstone J., Smith E. A., Trojanowska M.. Increased TGF-beta receptor type 1: Type H ratio leads to a novel ERK-dependent Smad independent upregulation of matrix gene program: A model for scleroderma. Arthritis and Rheumatism 2005; 52 (9):S174-S175.
Pannu R., Barbosa E., Singh A. K., Singh I.. Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in rats. Journal of Neuroscience Research 2005; 79 (3):340-350.
Pannu R., Barbosa E., Singh A. K., Singh I.. Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in rats. JOURNAL OF NEUROSCIENCE RESEARCH 2005; 79 (3):340-50.
Pannu R., Singh A. K., Singh I.. A novel role of lactosylceramide in the regulation of tumor necrosis factor alpha-mediated proliferation of rat primary astrocytes - Implications for astrogliosis following neurotrauma. Journal of Biological Chemistry 2005; 280 (14):13742-13751.
Pannu R., Singh A. K., Singh I.. A novel role of lactosylceramide in the regulation of TNF alpha-mediated proliferation of rat primary astrocytes. Journal of Neurochemistry 2005; 94 (Suppl. 1):86.
Pannu Ravinder, Singh Avtar K., Singh Inderjit. A novel role of lactosylceramide in the regulation of tumor necrosis factor alpha-mediated proliferation of rat primary astrocytes. Implications for astrogliosis following neurotrauma. Journal of Biological Chemistry 2005; 280 (14):13742-51.
Pansare V., Andea A., Kolizeras K., Che M., Grignon D., Sakr W.. Biochemical recurrence of patients with pathologically organ-confined prostate cancer (pT2) after radical prostatectomy: Analysis of patients demographics, pre-op PSA and tumor parameters in a cohort of 872 pT2 patients. Modern Pathology 2005; 18 ():157A.
Panzegrau Beata, Gordon Leonie, Goudy Glen H.. Outpatient therapeutic 131I for thyroid cancer. Journal of Nuclear Medicine Technology 2005; 33 (1):28-30.
Papadea C., Schlosser R. J.. Rapid method for beta(2)-transferrin in cerebrospinal fluid leakage using an automated immunofixation electrophoresis system. Clinical Chemistry 2005; 51 (2):464-470.
Pappa A., Brown D., Koutalos Y., DeGregori J., White C., Vasiliou V.. Human aldehyde dehydrogenase 3A1 inhibits proliferation and promotes survival of human corneal epithelial cells. Journal of Biological Chemistry 2005; 280 (30):27998-28006.
Pareek G., Wilkinson E. R., Schutt D., Will J. A., Warner T. F., Haemmerich D., Mahvi D., Nakada S. Y.. Haemostatic partial nephrectomy using bipolar radiofrequency ablation. Bju International 2005; 96 (7):1101-1104.
Park H. J., Zhang Y. L., Welzig C. M., Du C., Aronovitz M., Georgescu S. P., Mathews C. E., Liao R., Blaustein R. O., Karas R. H., Galper J. B.. A mouse model for diabetic autonomic neuropathy demonstrates decrease in both parasympathetic response and atrial expression GIRK1 (Kir3.1). Circulation 2005; 112 (17):U176-U176.
Park J. W., Spiess A., Osguthorpe J. D.. Benign calcified mass in tongue. Otolaryngology-Head and Neck Surgery 2005; 132 (1):146-147.
Park J. W., Spiess A., Osguthorpe J. D.. Benign calcified mass in tongue. Otolaryngology-Head and Neck Surgery 2005; 132 (1):146-147.
Parker R., Reeves H. M., Sudarshan S., Wolff D., Keane T.. Abnormal fluorescence in situ hybridization analysis in collecting duct carcinoma. Urology 2005; 66 (5):11109-111011.
Parks C. G., Cooper G. S., Hudson L. L., Dooley M. A., Treadwell E. L., St Clair E. W., Gilkeson G. S., Pandey J. P.. Association of Epstein-Barr virus with systemic lupus erythematosus - Effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype. Arthritis and Rheumatism 2005; 52 (4):1148-1159.
Pastis N. J., Nietert P. J., Silvestri G. A.. Variation in training for interventional pulmonary procedures among US pulmonary/critical care fellowships: a survey of fellowship directors. Chest 2005; 127 (5):1614-21.
Pastis N. J., Nietert P. J., Silvestri G. A., Committee American College of Chest Physicians Interventional Chest/Diagnostic Procedures Network Steering. Variation in training for interventional pulmonary procedures among US pulmonary/critical care fellowships: a survey of fellowship directors. CHEST 2005; 127 (5):1614-21.
Patel S. J., Shapiro W. R., Laske D. W., Jensen R. L., Asher A. L., Wessels B. W., Carpenter S. P., Shan J. S.. Safety and feasibility of convection-enhanced delivery of Cotara for the treatment of malignant glioma: initial experience in 51 patients. Neurosurgery 2005; 56 (6):1243-52; discussion 1252-3.
Patrick K. S., DeVane C. L., Malcolm R. J., Minhinnett R. R., Markowtiz J. S.. Influence of ethanol and gender on methylphenidate bioavailability, metabolism and response. Journal of Clinical Pharmacology 2005; 45 (9):1083-1083.
Patrick K. S., Williard R. L., Van Wert A. L., Dowd J. J., Oatis J. E Jr, Middaugh L. D.. Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol. JOURNAL OF MEDICINAL CHEMISTRY 2005; 48 (8):2876-81.
Patrick K. S., Williard R. L., VanWert A. L., Dowd J. J., Oatis J. E., Middaugh L. D.. Synthesis and pharmacology of ethylphenidate enantiomers: The human transesterification metabolite of methylphenidate and ethanol. JOURNAL OF MEDICINAL CHEMISTRY 2005; 48 (8):2876-2881.
Patrick Kennerly S., Gonzalez Mario A., Straughn Arthur B., Markowitz John S.. New methylphenidate formulations for the treatment of attention-deficit/hyperactivity disorder.[erratum appears in Expert Opin Drug Deliv. 2005 Mar;2(2):417]. Expert Opinion on Drug Delivery 2005; 2 (1):121-43.
Pawlow L. A., O'Neil P M., White M. A., Byrne T. K.. Findings and outcomes of psychological evaluations of gastric bypass applicants. Surgery for Obesity and Related Diseases 2005; 1 (6):523-529.
Pei Huiping, Li Chunyang, Adereth Yair, Hsu Tien, Watson Dennis K., Li Runzhao. Caspase-1 is a direct target gene of ETS1 and plays a role in ETS1-induced apoptosis. Cancer Research 2005; 65 (16):7205-13.
Peldschus K., Herzog P., Wood S. A., Cheema J. I., Costello P., Schoepf U. J.. Computer-aided diagnosis as a second reader - Spectrum of findings in CT studies of the chest interpreted as normal. Chest 2005; 128 (3):1517-1523.
Pelham W. E., Manos M. J., Ezzell C. E., Tresco K. E., Gnagy E. M., Hoffman M. T., Onyango A. N., Fabiano G. A., Lopez-Williams A., Wymbs B. T., Caserta D., Chronis A. M., Burrows-Maclean L., Morse G.. A dose-ranging study of a methylphenidate transdermal system in children with ADHD. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY 2005; 44 (6):522-529.
